These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15243584)
21. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884 [TBL] [Abstract][Full Text] [Related]
22. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Nam SY; Amoscato AA; Lee YJ Oncogene; 2002 Jan; 21(3):337-46. PubMed ID: 11821946 [TBL] [Abstract][Full Text] [Related]
23. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Aggarwal BB; Bhardwaj U; Takada Y Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190 [TBL] [Abstract][Full Text] [Related]
24. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT. Efron PA; Chen MK; Iyengar M; Dai W; Nagaram A; Beierle EA J Pediatr Surg; 2006 Jun; 41(6):1072-80. PubMed ID: 16769337 [TBL] [Abstract][Full Text] [Related]
25. Selection for TRAIL resistance results in melanoma cells with high proliferative potential. Wu JJ; Zhang XD; Gillespie S; Hersey P FEBS Lett; 2005 Mar; 579(9):1940-4. PubMed ID: 15792800 [TBL] [Abstract][Full Text] [Related]
26. alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Kadekaro AL; Kavanagh R; Kanto H; Terzieva S; Hauser J; Kobayashi N; Schwemberger S; Cornelius J; Babcock G; Shertzer HG; Scott G; Abdel-Malek ZA Cancer Res; 2005 May; 65(10):4292-9. PubMed ID: 15899821 [TBL] [Abstract][Full Text] [Related]
27. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor. Whang YE; Yuan XJ; Liu Y; Majumder S; Lewis TD Vitam Horm; 2004; 67():409-26. PubMed ID: 15110188 [TBL] [Abstract][Full Text] [Related]
28. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Sui X; Krantz SB; Zhao ZJ Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Chandrasekar N; Mohanam S; Gujrati M; Olivero WC; Dinh DH; Rao JS Oncogene; 2003 Jan; 22(3):392-400. PubMed ID: 12545160 [TBL] [Abstract][Full Text] [Related]
30. PI3K/Akt signalling pathway and cancer. Fresno Vara JA; Casado E; de Castro J; Cejas P; Belda-Iniesta C; González-Barón M Cancer Treat Rev; 2004 Apr; 30(2):193-204. PubMed ID: 15023437 [TBL] [Abstract][Full Text] [Related]
31. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. Dhandapani KM; Wade FM; Wakade C; Mahesh VB; Brann DW J Neurochem; 2005 Oct; 95(1):9-19. PubMed ID: 16181409 [TBL] [Abstract][Full Text] [Related]
32. Phosphatidylinositol 3-kinase/Akt-dependent and -independent protection against apoptosis in normal human melanocytes. Oka M; Kageyama A; Fukunaga M; Bito T; Nagai H; Nishigori C J Invest Dermatol; 2004 Nov; 123(5):930-6. PubMed ID: 15482482 [TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. Morel J; Audo R; Hahne M; Combe B J Biol Chem; 2005 Apr; 280(16):15709-18. PubMed ID: 15684417 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells. Beresford SA; Davies MA; Gallick GE; Donato NJ J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162 [TBL] [Abstract][Full Text] [Related]
35. S100B as a potential biomarker for the detection of cytotoxicity of melanocytes. Cheong KA; Noh M; Kim CH; Lee AY Exp Dermatol; 2014 Mar; 23(3):165-71. PubMed ID: 24451020 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Barnett SF; Defeo-Jones D; Fu S; Hancock PJ; Haskell KM; Jones RE; Kahana JA; Kral AM; Leander K; Lee LL; Malinowski J; McAvoy EM; Nahas DD; Robinson RG; Huber HE Biochem J; 2005 Jan; 385(Pt 2):399-408. PubMed ID: 15456405 [TBL] [Abstract][Full Text] [Related]
37. Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells. Lane D; Robert V; Grondin R; Rancourt C; Piché A Int J Cancer; 2007 Sep; 121(6):1227-37. PubMed ID: 17534891 [TBL] [Abstract][Full Text] [Related]
38. A phosphatidyl-inositol-3-kinase-dependent anti-inflammatory pathway activated by Salmonella in epithelial cells. Huang FC; Li Q; Cherayil BJ FEMS Microbiol Lett; 2005 Feb; 243(1):265-70. PubMed ID: 15668028 [TBL] [Abstract][Full Text] [Related]
39. RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma. Laugier F; Finet-Benyair A; André J; Rachakonda PS; Kumar R; Bensussan A; Dumaz N Oncotarget; 2015 Sep; 6(29):28120-31. PubMed ID: 26356562 [TBL] [Abstract][Full Text] [Related]